Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,459 | 854 | 98.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $203.30 | 11 | 1.0% |
| Education | $123.58 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $1,570 | 43 | $0 (2024) |
| Amgen Inc. | $1,414 | 58 | $0 (2023) |
| Neurelis, Inc. | $1,282 | 42 | $0 (2024) |
| ABBVIE INC. | $1,217 | 57 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $1,009 | 58 | $0 (2022) |
| UCB, Inc. | $1,004 | 78 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $885.84 | 34 | $0 (2022) |
| Allergan, Inc. | $875.01 | 45 | $0 (2022) |
| Lilly USA, LLC | $870.84 | 40 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $850.93 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,226 | 112 | Otsuka America Pharmaceutical, Inc. ($451.82) |
| 2023 | $3,324 | 131 | Otsuka America Pharmaceutical, Inc. ($399.11) |
| 2022 | $3,221 | 155 | UCB, Inc. ($287.93) |
| 2021 | $3,166 | 160 | AbbVie Inc. ($389.34) |
| 2020 | $1,903 | 93 | Allergan, Inc. ($382.43) |
| 2019 | $1,939 | 84 | EISAI INC. ($471.17) |
| 2018 | $1,957 | 88 | Eisai Inc. ($538.79) |
| 2017 | $1,049 | 47 | Eisai Inc. ($190.52) |
All Payment Transactions
870 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/06/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Neurology | ||||||
| 11/14/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Analgesic | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: EPILEPSY | ||||||
| 11/08/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Neurology | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: AMANTADINE | ||||||
| 11/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: Neurology | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: EPILEPSY | ||||||
| 10/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,130 | 3,076 | $455,467 | $332,230 |
| 2022 | 20 | 2,419 | 3,636 | $672,922 | $392,772 |
| 2021 | 20 | 2,459 | 3,926 | $696,787 | $429,824 |
| 2020 | 22 | 2,080 | 3,443 | $572,533 | $341,079 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92537 | Assessment and recording of balance system during hot and cold irrigation of both ears | Office | 2021 | 155 | 159 | $10,548 | $6,090 | 57.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 74 | 99 | $8,172 | $5,279 | 64.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $5,009 | $3,873 | 77.3% |
| 20526 | Injection of carpal tunnel | Office | 2021 | 32 | 41 | $5,788 | $3,405 | 58.8% |
| 64445 | Injection of anesthetic agent and/or steroid into sciatic nerve of lower back and leg | Office | 2021 | 17 | 23 | $6,618 | $2,954 | 44.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 57 | 136 | $5,147 | $1,796 | 34.9% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 12 | 15 | $1,924 | $1,261 | 65.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 52 | 293 | $2,930 | $300.08 | 10.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 48 | 110 | $917.22 | $144.70 | 15.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 391 | 720 | $113,080 | $70,755 | 62.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 329 | 851 | $91,193 | $59,914 | 65.7% |
| 93886 | Ultrasound scanning of head and neck vessel blood flow (inside the brain) | Office | 2020 | 160 | 162 | $72,568 | $43,569 | 60.0% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 140 | 143 | $46,578 | $28,073 | 60.3% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2020 | 85 | 89 | $53,531 | $22,284 | 41.6% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2020 | 45 | 47 | $25,514 | $19,778 | 77.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 96 | 199 | $28,113 | $18,608 | 66.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 169 | 169 | $25,226 | $16,915 | 67.1% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Office | 2020 | 51 | 52 | $21,002 | $16,902 | 80.5% |
| 92546 | Assessment and recording of abnormal eye movement with patient in a rotating chair | Office | 2020 | 117 | 117 | $25,154 | $12,915 | 51.3% |
| 92540 | Observation, testing, and recording of abnormal eye movement | Office | 2020 | 118 | 118 | $20,525 | $11,969 | 58.3% |
| 92537 | Assessment and recording of balance system during hot and cold irrigation of both ears | Office | 2020 | 118 | 118 | $13,297 | $4,556 | 34.3% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 15 | 15 | $5,714 | $2,725 | 47.7% |
| 20526 | Injection of carpal tunnel | Office | 2020 | 23 | 30 | $3,919 | $2,403 | 61.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 15 | 34 | $8,897 | $2,127 | 23.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $2,876 | $1,904 | 66.2% |
About Dr. Sergey Zhivotenko, MD
Dr. Sergey Zhivotenko, MD is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154348092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sergey Zhivotenko, MD has received a total of $19,786 in payments from pharmaceutical and medical device companies, with $3,226 received in 2024. These payments were reported across 870 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($19,459).
As a Medicare-enrolled provider, Zhivotenko has provided services to 9,088 Medicare beneficiaries, totaling 14,081 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Brooklyn, NY
- Active Since 07/16/2006
- Last Updated 03/28/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154348092
Products in Payments
- Fycompa (Drug) $1,545
- VALTOCO (Drug) $1,282
- Aimovig (Biological) $1,279
- Horizant (Drug) $1,136
- NUEDEXTA (Drug) $1,116
- Briviact (Drug) $971.60
- RYTARY (Drug) $778.72
- UBRELVY (Drug) $767.61
- NUPLAZID (Drug) $672.85
- QULIPTA (Drug) $576.20
- EMGALITY (Drug) $537.57
- REXULTI (Drug) $487.06
- INGREZZA (Drug) $446.85
- Auvelity (Drug) $435.35
- Dhivy (Drug) $409.88
- BOTOX (Biological) $409.26
- Gocovri (Drug) $355.36
- GOCOVRI (Drug) $280.51
- Ongentys (Drug) $266.06
- NURTEC ODT (Drug) $265.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680